Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 34.93M
March 31, 2026 35.01M
December 31, 2025 0.0557M
September 30, 2025 -11.07M
June 30, 2025 0.6782M
March 31, 2025 21.18M
December 31, 2024 -0.5204M
September 30, 2024 -17.54M
June 30, 2024 3.580M
March 31, 2024 0.00
December 31, 2023 -0.3196M
September 30, 2023 -0.9159M
June 30, 2023 -1.896M
March 31, 2023 -232.63M
December 31, 2022 -0.7449M
September 30, 2022 -4.403M
June 30, 2022 1.248M
March 31, 2022 -0.0935M
December 31, 2021 -265.43M
September 30, 2021 -7.918M
June 30, 2021 -1.203M
March 31, 2021 -186.49M
December 31, 2020 -5.848M
September 30, 2020 -5.598M
June 30, 2020 -2.77M
Date Value
March 31, 2020 -402.09M
December 31, 2019 0.3279M
September 30, 2019 -1.353M
June 30, 2019 0.4973M
March 31, 2019 0.00
December 31, 2018 0.6623M
September 30, 2018 0.0125M
June 30, 2018 -0.8752M
March 31, 2018 0.00
December 31, 2017 25.90M
September 30, 2017 -30.53M
June 30, 2017 0.1396M
March 31, 2017 -0.9442M
December 31, 2016 95.00M
September 30, 2016 0.3347M
June 30, 2016 -94.13M
March 31, 2016 -0.3696M
December 31, 2015 -1.556M
September 30, 2015 -0.2812M
June 30, 2015 -0.6274M
March 31, 2015 -1.766M
December 31, 2014 -46.82M
September 30, 2014 0.0039M
June 30, 2014 -0.3857M
March 31, 2014 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Evaxion AS 0.00
Genmab A/S -1.255M
Ascendis Pharma A/S 38.47M
Zealand Pharma A/S 66.43M
Agenus, Inc. -14.71M